chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ?Patients who meet the diagnosis of stable stage of chronic obstructive pulmonary disease; ? Age 40~80 years old; ?Patients with lung qi deficiency, lung spleen qi deficiency, or lung kidney qi deficiency; ?Not participating in clinical studies of other interventions within 1 month prior to enrolment; ?Able to tolerate YFM therapy; ?Voluntary acceptance of the treatment and signing of the informed consent form.
Exclusion criteria
Exclusion criteria: ?Pregnant and lactating women; ? Patients with delirium, dementia, and various psychiatric disorders; ? Combined severe cardiac insufficiency, liver and kidney diseases; ? Combined active tuberculosis, diffuse panfine bronchitis, pneumothorax, pleural effusion, pulmonary embolism, tumour; ?Those who are known to be allergic to the drug composition of YFM.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of acute exacerbations; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms and signs;mMRC;6MWD;CAT;mESQ-COPD;SF-36;mCOPD-PRO;Number of colds;Biological indicators;Biochemical indicators;Pulmonary function; | — |
Countries
China
Contacts
The First Affiliated Hospital of Henan University of CM